Form 4 for TMDX TransMedics Group, Inc.
Accepted 2022-01-07 00:00:00 ET · period of report 2022-01-06 · accession 0000899243-22-001372 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-07 | 2022-01-06 | TMDX | Hassanein Waleed H | Pres, CEO, Dir | M - OptEx | $0.28 | +122.4K | 526.2K | +30% | +$34.3K |
| D | 2022-01-07 | 2022-01-06 | TMDX | Hassanein Waleed H | Pres, CEO, Dir | M - OptEx | $0.00 | -122.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-06 | M | A | 122,371 | $0.28 | 526,214 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-06 | M | D | 122,371 | $0.00 | 0 | D | $0.28 · — to 2023-05-29 | 122,371 Common Stock | (F2) The option is fully vested. |